Lopez-Jimenez, Francisco
Deshmukh, Abhishek
Bisognano, John
Boehmer, John
Ramasamy, Mouli
Shyam Kumar, Prashanth
Kapa, Suraj
Varadan, Venk
Varadan, Vijay
Fudim, Marat https://orcid.org/0000-0002-8671-7007
Funding for this research was provided by:
Nanowear Inc.
Article History
Received: 23 September 2024
Accepted: 28 December 2024
First Online: 13 January 2025
Declarations
: An independent Institutional Review Board (IRB), Advarra Inc. (Columbia, MD, USA), approved the protocol (IRB protocol #14–90-0093). This study was conducted in accordance with the of Helsinki and in compliance with relevant FDA regulations. All subjects provided written informed consent prior to participation and completed the study. Conflicts of interest pertinent to the study are provided in the following section titled disclosures.
: • A. Deshmukh, F. Lopez-Jimenez, J. Bisognano, and M. Fudim report no relevant conflicts of interest.• S. Kapa, J. Boehmer, are advisors for Nanowear, Inc with potential equity benefit but no direct cash compensation.• M. Ramasamy, P. Kumar, V. Varadan, V. Varadan are employees of Nanowear, Inc and receive both equity and cash compensation benefits.• M. Fudim is an editor in this journal.